LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

Inicio・Lista de Acciones・Medpace Holdings Inc

Medpace Holdings Inc

Cerrado

SectorSanidad

452.73 -1.22

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

445.18

Máximo

458.34

Métricas clave
By Trading Economics
Ingresos	-11M 124M
Ventas	-1.8M 707M
P/B Media del Sector	28.43 49.888
BPA	4.28
Margen de beneficios	17.53
Empleados	6,300
EBITDA	-16M 148M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	-2.44% downside

Dividendos
By Dow Jones
Próximas Ganancias	20 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-2.2B 13B
Apertura anterior	453.95
Cierre anterior	452.73

Medpace Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 oct 2025, 15:15 UTC

Ganancias

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Comparación entre iguales

Cambio de precio

Medpace Holdings Inc previsión

Precio Objetivo

By TipRanks

-2.44% descenso

Estimación a 12 Meses

Media 447.5 USD -2.44%

Máximo 495 USD

Mínimo 393 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medpace Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Medpace Holdings Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.